Filter Results :

Your search for Immune returned 154 reports

Sort by


TapImmune Inc. (TPIV) - Financial and Strategic SWOT Analysis Review

06 Apr 2015  |  Published by:  GlobalData
SummaryTapImmune Inc. (TapImmune) is a biotechnology company. The company develops peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. Its immunotherapy technologies are used to prevent emerging viral pathogens for pandemics and biodefense. Ta...

$ 300.00

Read More

The 2016-2021 World Outlook for Autoimmune Disease Therapeutics

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for autoimmune disease therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share...

$ 995.00

Read More

Primary Immune Deficiency (PID)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Primary Immune Deficiency (PID)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Primary Immune Deficiency (PID). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-l...

$ 1,250.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Idiopathic Thrombocytopenic Purpura (Immune Thombocytopenic Purpura). The main objective of this report to track competitor pipelin...

$ 1,250.00

Read More

The 2016-2021 World Outlook for Veterinary Blood Derivatives, Antitoxins, Immune Serums, and Allergens

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for veterinary blood derivatives, antitoxins, immune serums, and allergens across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in milli...

$ 995.00

Read More

The 2016-2021 World Outlook for Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for antitoxins, antivenoms, immune globulins, and therapeutic immune serums for therapeutic use and passive immunization excluding diagnostics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potenti...

$ 995.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). The main objective of this report to track competitor pipel...

$ 1,250.00

Read More

The 2016 Report on Autoimmune Disease Therapeutics: World Market Segmentation by City

01 Apr 2015  |  Published by:  Icon Group International, Inc
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report cov...

$ 995.00

Read More

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2015,report provides Acquired (Autoimmune) Hemolytic Anemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File...

$ 1,250.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-API Insights, 2015,report provides Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs marketed details and API Manufacturers details across the globe along with the location. The rep...

$ 1,250.00

Read More

The 2016 Report on Antitoxins, Antivenoms, Immune Globulins, and Therapeutic Immune Serums for Therapeutic Use and Passive Immunization Excluding Diagnostics: World Market Segmentation by City

01 Apr 2015  |  Published by:  Icon Group International, Inc
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report cov...

$ 995.00

Read More

Autoimmune Technologies, LLC - Product Pipeline Analysis

31 Mar 2015  |  Published by:  GlobalData
SummaryAutoimmune Technologies, LLC (Autoimmune) is a biomedical company that develops medical diagnostic tests, explores disease mechanisms and investigates therapies for autoimmune diseases and disorders. Its laboratory tests include fibromyalgia, lassa fever, gulf war syndrome, lupus, juvenile RA...

$ 750.00

Read More

Immune Design Corp. (IMDZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

30 Mar 2015  |  Published by:  GlobalData
SummaryImmune Design Corp. (Immune Design) is a biotechnology company. The company discovers and develops vaccines for the treatment of cancer, infectious diseases, allergy and autoimmune disorders. Its immuno-oncology products include ID-LV305, ID-G305, ID-CMB305 and ID-G100. Immune Design develops...

$ 250.00

Read More

TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

30 Mar 2015  |  Published by:  GlobalData
SummaryTapImmune Inc. (TapImmune) is a biotechnology company. The company develops peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. Its immunotherapy technologies are used to prevent emerging viral pathogens for pandemics and biodefense. Ta...

$ 250.00

Read More

DecImmune Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

30 Mar 2015  |  Published by:  GlobalData
SummaryDecImmune Therapeutics, Inc. (DecImmune) is a pharmaceutical company. The company develops monoclonal antibody therapeutics for the treatment of heart diseases. It is developing an antibody therapeutic to restrict acute inflammation and prevent tissue damage following vascular injury by inhib...

$ 250.00

Read More
Total 154 records.